CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 64 enrolled
Drug / intervention
Intrathecal Clonidine +2 moredrug
Likely dose
Intrathecal Clonidine 75 mcgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02550444
NCT02550444N/ACompleted

Comparison Between Intravenous and Intrathecal Clonidine in Post-cesarean Analgesia

University of Sao Paulo General Hospital·interventional·Posted Sep 15, 2015·Updated Nov 1, 2017

In Brief

A clinical study evaluating Intrathecal Clonidine, Intravenous Clonidine, and 1 other intervention for Pregnancy. Completed, enrolled 64 participants.

Detailed Summary

The purpose of this study is to evaluate effects of intravenous clonidine in acute and chronic post-cesarean pain, possible adverse effects over mother-newborn pair, in comparison to intrathecal adjuvant clonidine and placebo.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPregnancy
Countries--
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedSep 15, 2015
Enrollment StartApr 1, 2015
Primary CompletionMay 1, 2015
Study CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 10.8 years ago

Interventions

Intrathecal Clonidinedrug

Intrathecal Adjuvant Clonidine 75 mcg; Intravenous Placebo (Saline 0,9%); Intrathecal heavy Bupivacaine 0,5% (15mg), morphine 0,02 (80mcg) and fentanyl (10mcg).

Intravenous Clonidinedrug

Intravenous Clonidine 75 mcg; Intrathecal Placebo (Saline 0,9%); Intrathecal heavy Bupivacaine 0,5% (15mg), morphine 0,02 (80mcg) and fentanyl (10mcg).

Placebodrug

Intravenous and intrathecal Placebo (Saline 0,9%); Intrathecal heavy Bupivacaine 0,5% (15mg), morphine 0,02 (80mcg) and fentanyl (10mcg).